Skip to main content
Delic Holdings Corp. logo

Delic Holdings Corp. — Investor Relations & Filings

Ticker · DELCF ISIN · CA24689E1079 LEI · 8945004HTB9451S6LV82 CSE Human health and social work activities
Open in API
Filings indexed 264 across all filing types
Latest filing 2021-08-26 Regulatory Filings
Country CA Canada
Listing CSE DELCF

About Delic Holdings Corp.

https://thedelic.com

Delic Holdings Corp. is a psychedelic wellness corporation committed to delivering safe, legal, and science-backed benefits. The company operates an integrated ecosystem spanning media, science, and health services. Its core business involves owning and operating a chain of psychedelic wellness clinics, establishing one of the largest infrastructures in the sector. Delic provides various medicines and treatments, aiming to improve access to health benefits. Additionally, the company focuses on developing intellectual property and manages "The Delic," a creative platform dedicated to reframing the public conversation surrounding new medicines and treatments.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the formation of a Medical Advisory Board by Delic Holdings Corp. It focuses on the company's commitment to science and psychedelic wellness, describing the members of the advisory board and their expertise. There is no financial data, no mention of quarterly or annual results, no regulatory filings, no voting results, no management changes, no capital or financing updates, and no legal proceedings. The document is a corporate announcement about advisory board formation and company strategy, typical of a general regulatory announcement or news release. It does not fit into any specific financial report or regulatory filing category but is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other categories. The document length is over 10,000 characters, so it is not a brief report publication announcement (RPA).
2021-08-26 English
News release - English.pdf
Regulatory Filings
2021-08-24 English
Other.PDF
Regulatory Filings
2021-08-17 English
Other material contracts (amended) - English.PDF
Regulatory Filings
2021-08-17 English
Other.PDF
Regulatory Filings
2021-08-17 English
Other.PDF
Regulatory Filings Classification · 100% confidence The document is an official authorization letter from Health Canada granting permission to Complex Biotech Discovery Ventures Ltd. to possess and use a restricted drug (Psilocybin) for scientific research purposes. It details conditions, limitations, record-keeping requirements, and compliance obligations related to the authorization. There are no financial statements, management discussions, or corporate governance information. The document is regulatory in nature, related to controlled substances compliance, and does not fit into financial or corporate filing categories such as Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement or a certification but a regulatory authorization letter. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory documents that do not fit other categories.
2021-08-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.